Brian Druker
Director/Board Member at AMGEN INC.
Net worth: 2 M $ as of 30/03/2024
Brian Druker active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AMGEN INC. | Director/Board Member | 22/05/2018 | - |
| Independent Dir/Board Member | 22/05/2018 | - | |
| VINCERX PHARMA, INC. | Director/Board Member | 22/12/2020 | - |
| Independent Dir/Board Member | 22/12/2020 | - | |
| Oregon Health & Science University | Director/Board Member | 30/06/2007 | - |
| Corporate Officer/Principal | 30/06/2000 | - | |
The Burroughs Wellcome Fund
 The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Director/Board Member | - | - |
| OHSU Knight Cancer Institute | Director/Board Member | 30/06/2007 | - |
Career history of Brian Druker
Former positions of Brian Druker
| Companies | Position | Start | End |
|---|---|---|---|
MolecularMD Corp.
 MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Founder | 31/12/2004 | - |
| BLUEPRINT MEDICINES CORPORATION | Founder | 03/10/2008 | - |
Training of Brian Druker
| University of California San Diego | Doctorate Degree |
Statistics
International
| United States | 9 |
Operational
| Director/Board Member | 5 |
| Founder | 2 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| VINCERX PHARMA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
MolecularMD Corp.
MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Health Services |
| OHSU Knight Cancer Institute |
- Stock Market
- Insiders
- Brian Druker
- Experience
